GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Abroad (travel likely)RecruitingPHASE2
Conditions
Cystic Fibrosis · Pancreatic Insufficiency · Abnormal Glucose Tolerance · Diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital of Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Christine Chan, MD) · Christinel.Chan@childrenscolorado.org · 720-777-0990Christine Chan, MD (Sub-investigator)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Paola Alvarado, MS) · Paola.Alvarado@pennmedicine.upenn.edu · 215-746-2081Contact: Principal Investigator (Michael Rickels, MD, MS)Contact: Principal Investigator (Andrea Kelly, MD, MS)Christine Chan, MD (Sub-investigator)
Study leads
Michael R Rickels, MD, MS
Principal Investigator
University of Pennsylvania
Andrea Kelly, MD, MSCE
Principal Investigator
Children's Hospital of Philadelphia